Axsome Therapeutics Inc. (AXSM)
109.90
-1.77 (-1.59%)
At close: Apr 02, 2025, 3:59 PM
107.50
-2.18%
After-hours: Apr 02, 2025, 05:06 PM EDT
Axsome Therapeutics Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -287.22M | -239.24M | -187.13M | -130.4M | -102.9M | -68.35M | -30.97M | -28.94M | -27.2M | -10.56M | -6M | -2.17M |
| Depreciation & Amortization | n/a | 6.83M | 5.56M | 1.16M | 77.72K | 37.33K | 48.94K | 42.56K | 20.48K | 3.54K | n/a | n/a |
| Stock-Based Compensation | 85.22M | 62.62M | 37.73M | 20.8M | 14.76M | 6.12M | 1.75M | 2.07M | 2.03M | 803.28K | 376.81K | 55.28K |
| Other Working Capital | 33.9M | 34.81M | 41.19M | 679.48K | -2.15M | 7.91M | 1.27M | -113.83K | 1.61M | -196.48K | -84.14K | -5.05K |
| Other Non-Cash Items | 39.69M | 53.1M | 3.66M | -104.61K | 7.95M | 649.99K | 375.63K | 470.52K | 68.93K | -902.22K | 512.67K | 327.19K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | 1.25M | n/a | -2.79M | 646K | n/a | 2.28M | n/a | n/a |
| Change in Working Capital | 33.9M | -28.39M | 23.67M | 324.79K | 412.04K | 15.17M | 1.52M | -759.55K | 3.8M | 937.73K | 514.69K | 153.09K |
| Operating Cash Flow | -128.41M | -145.08M | -116.51M | -108.23M | -78.46M | -46.38M | -30.05M | -26.47M | -21.28M | -7.44M | -4.6M | -1.63M |
| Capital Expenditures | -270K | -582K | -702.11K | -307.55K | -45.89K | -16.12K | -32.7K | -9.9K | -104.56K | -20.2K | n/a | n/a |
| Acquisitions | n/a | n/a | -53M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -270K | n/a | -53,702.1B | -307.55B | -45.89B | -16.12B | -32.7B | -9.9B | -104.56M | -20.2K | n/a | n/a |
| Investing Cash Flow | -270K | -582K | -53.7M | -307.55K | -45.89K | -16.12K | -32.7K | -9.9K | -104.56K | -20.2K | n/a | n/a |
| Debt Repayment | -990K | 85M | 45M | n/a | 28.34M | 12.76M | -3.33M | -277.78K | 10M | 7.34M | 5.19M | 3.78M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 18.05M | -12.74M | -4.18M | 11,129.7B | -52.76K | 1.39M | 486.03K | 484.61K | -31.9K | -12.49K | -62.52K | -57.98K |
| Financial Cash Flow | 57.84M | 331.01M | 284.58M | 11.13M | 42.41M | 252.39M | 10.03M | 23.88M | 9.97M | 52.88M | 5.13M | 3.72M |
| Net Cash Flow | -70.84M | 185.35M | 114.37M | -97.4M | -36.09M | 206M | -20.05M | -2.6M | -11.42M | 45.42M | 529.97K | 2.09M |
| Free Cash Flow | -128.68M | -145.66M | -117.21M | -108.53M | -78.5M | -46.39M | -30.09M | -26.48M | -21.39M | -7.46M | -4.6M | -1.63M |